New antibiotics for the treatment of serious infections in intensive care unit patients.
Curr Med Res Opin
; 35(8): 1331-1334, 2019 08.
Article
en En
| MEDLINE
| ID: mdl-30760041
ABSTRACT
Objective:
Nowadays, the infections of patients admitted to intensive care units (ICUs) are a major public health problem; this is due to several factors, in primis an increase in antibiotic resistance and the inappropriate use of antibiotics.Methods:
We briefly focus on on both new antibiotics approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) in the last decade (2010-2019), and on agents in an advanced phase of development that have been developed, or are already approved, for the treatment of serious infections due to multidrug-resistant bacteria, both Gram-positive and Gram-negative bacteria.Results:
An adequate knowledge of the new antibiotics will reduce their inappropriate use with the consequent reduction in the onset of new resistance and decreasing health care costs.Conclusion:
Antimicrobial stewardship programs to optimize antimicrobial prescribing and to preserve the effectiveness of the new antimicrobial agents are urgently needed'.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infecciones Bacterianas
/
Infección Hospitalaria
/
Farmacorresistencia Bacteriana Múltiple
/
Unidades de Cuidados Intensivos
/
Antibacterianos
Límite:
Humans
Idioma:
En
Revista:
Curr Med Res Opin
Año:
2019
Tipo del documento:
Article
País de afiliación:
Italia
Pais de publicación:
ENGLAND
/
ESCOCIA
/
GB
/
GREAT BRITAIN
/
INGLATERRA
/
REINO UNIDO
/
SCOTLAND
/
UK
/
UNITED KINGDOM